TrialX, in collaboration with investigators at the University of Iowa is proud to announce that the SAYSTOP Study App, developed to study antibiotic resistance using our remote data collection solution, has successfully completed enrollment. The “Study of…
When Ryan Frazier was only three months old, his family received life-changing news: he had acute myeloid leukemia (AML). Despite multiple rounds of chemotherapy, the cancer came back and spread to his central nervous system. His…
The 15th annual DPHARM: Disruptive Innovations to Modernize Clinical Research (September 16–17, 2025, Philadelphia, PA) brought together senior clinical operations executives, patient advocates, and technology leaders to explore the future of clinical trials. AI, patient-centric trial…
🏈 Kicking Off Progress in ALS Research – We’re honored to share that TrialX’s global clinical trial finder now powers the ALS Network’s Trial Finder—an AI-driven platform designed to help individuals easily discover clinical trials focused on amyotrophic…
“I get so excited when I read about new treatments and developments in the fight against ovarian cancer. I would love more than anything to one day see a discovery that will prevent this disease altogether….
When Len Gardner was admitted to the NIH Clinical Center in 1955, he joined a clinical study that would ultimately save his life. Diagnosed with a serious kidney condition, he received an experimental drug—now known as…
Each year, more than 209,000 people in the U.S. are diagnosed with lung cancer, making it one of the most common—and challenging—cancers today. These numbers highlight not only the need for better treatments but also the…
